MedPath

APO-POMALIDOMIDE

APO-POMALIDOMIDE

Approved
DIN Number

02520435

Drug Class

Human

Market Date

Feb 28, 2023

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02520435
AIG Number0155290002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX06 POMALIDOMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

POMALIDOMIDEActive
Strength: 2 MG
Monograph: POMALIDOMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.